These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 35247806)

  • 1. Identification of Small-molecule YAP-TEAD inhibitors by High-throughput docking for the Treatment of colorectal cancer.
    Li L; Li R; Wang Y
    Bioorg Chem; 2022 May; 122():105707. PubMed ID: 35247806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a new class of reversible TEA domain transcription factor inhibitors with a novel binding mode.
    Hu L; Sun Y; Liu S; Erb H; Singh A; Mao J; Luo X; Wu X
    Elife; 2022 Nov; 11():. PubMed ID: 36398861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs.
    Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J
    FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutations.
    Troilo A; Benson EK; Esposito D; Garibsingh RA; Reddy EP; Mungamuri SK; Aaronson SA
    Oncotarget; 2016 May; 7(20):28765-82. PubMed ID: 27144834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging the Fragment Molecular Orbital and MM-GBSA Methods in Virtual Screening for the Discovery of Novel Non-Covalent Inhibitors Targeting the TEAD Lipid Binding Pocket.
    Kim J; Jin H; Kim J; Cho SY; Moon S; Wang J; Mao J; No KT
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear actin regulates cell proliferation and migration via inhibition of SRF and TEAD.
    McNeill MC; Wray J; Sala-Newby GB; Hindmarch CCT; Smith SA; Ebrahimighaei R; Newby AC; Bond M
    Biochim Biophys Acta Mol Cell Res; 2020 Jul; 1867(7):118691. PubMed ID: 32119877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription.
    Kulkarni A; Mohan V; Tang TT; Post L; Chan YC; Manning M; Thio N; Parker BL; Dawson MA; Rosenbluh J; Vissers JH; Harvey KF
    EMBO Rep; 2024 Sep; 25(9):3944-3969. PubMed ID: 39103676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological blockade of TEAD-YAP reveals its therapeutic limitation in cancer cells.
    Sun Y; Hu L; Tao Z; Jarugumilli GK; Erb H; Singh A; Li Q; Cotton JL; Greninger P; Egan RK; Tony Ip Y; Benes CH; Che J; Mao J; Wu X
    Nat Commun; 2022 Nov; 13(1):6744. PubMed ID: 36347861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal β-strand in YAP is critical for stronger binding to scalloped relative to TEAD transcription factor.
    Bokhovchuk F; Mesrouze Y; Meyerhofer M; Fontana P; Zimmermann C; Villard F; Erdmann D; Kallen J; Scheufler C; Velez-Vega C; Chène P
    Protein Sci; 2023 Jan; 32(1):e4545. PubMed ID: 36522189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Inhibition of the YAP : TEAD Interaction: An Unprecedented Drug Discovery Challenge.
    Chène P
    ChemMedChem; 2024 Jun; ():e202400361. PubMed ID: 38863297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Overview of TEAD4 in Cancer Biology.
    Chen M; Huang B; Zhu L; Chen K; Liu M; Zhong C
    Onco Targets Ther; 2020; 13():9865-9874. PubMed ID: 33116572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders.
    Li H; Ge Z; Lin K; He W; Chu Q; Zheng M; Zhang S; Xu T
    ACS Med Chem Lett; 2024 May; 15(5):631-639. PubMed ID: 38746898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment and High-Throughput Drug-Combination Profiling of TEAD-Palmitoylation Inhibitors in Hippo Pathway Deficient Mesothelioma.
    Evsen L; Morris PJ; Thomas CJ; Ceribelli M
    Pharmaceuticals (Basel); 2023 Nov; 16(12):. PubMed ID: 38139762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration.
    Fnaiche A; Chan HC; Paquin A; González Suárez N; Vu V; Li F; Allali-Hassani A; Cao MA; Szewczyk MM; Bolotokova A; Allemand F; Gelin M; Barsyte-Lovejoy D; Santhakumar V; Vedadi M; Guichou JF; Annabi B; Gagnon A
    ACS Med Chem Lett; 2023 Dec; 14(12):1746-1753. PubMed ID: 38116405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Epigenetic and Molecular Analysis Reveals a Novel Promoter for a New Isoform of the Transcription Factor TEAD4.
    Rashidiani S; Mamo G; Farkas B; Szabadi A; Farkas B; Uszkai V; Császár A; Brandt B; Kovács K; Pap M; Rauch TA
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of yes activated protein (YAP) in melanoma metastasis.
    Leask A; Nguyen J; Naik A; Chitturi P; Riser BL
    iScience; 2024 Jun; 27(6):109864. PubMed ID: 38770136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docking analysis of verteporfin with YAP WW domain.
    Kandoussi I; Lakhlili W; Taoufik J; Ibrahimi A
    Bioinformation; 2017; 13(7):237-240. PubMed ID: 28943729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of TEAD4 in TNBC: in-silico inhibition of the TEAD4-YAP interaction by flufenamic acid analogs.
    Gupta SRR; Singh S; Rustagi V; Pahuja M; Mangangcha IR; Rinchui M; Jha SK; Singh A; Singh IK
    In Silico Pharmacol; 2024; 12(2):64. PubMed ID: 39035099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP condensates are highly organized hubs.
    Hao S; Lee YJ; Benhamou Goldfajn N; Flores E; Liang J; Fuehrer H; Demmerle J; Lippincott-Schwartz J; Liu Z; Sukenik S; Cai D
    iScience; 2024 Jun; 27(6):109927. PubMed ID: 38784009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TEAD-YAP Interaction Inhibitors and MDM2 Binders from DNA-Encoded Indole-Focused Ugi Peptidomimetics.
    Kunig VBK; Potowski M; Akbarzadeh M; Klika Škopić M; Dos Santos Smith D; Arendt L; Dormuth I; Adihou H; Andlovic B; Karatas H; Shaabani S; Zarganes-Tzitzikas T; Neochoritis CG; Zhang R; Groves M; Guéret SM; Ottmann C; Rahnenführer J; Fried R; Dömling A; Brunschweiger A
    Angew Chem Int Ed Engl; 2020 Nov; 59(46):20338-20342. PubMed ID: 32537835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.